Skip to content
Home/Companies/Healthcare/Alderley Analytical

Alderley Analytical

Healthcare·UK·Exited 2024·Held 9yr
Entry
2015
Hold
9yr
Exit
2024

Who owns Alderley Analytical?

Alderley Analytical is a British Healthcare company, now owned by Synexa Life Sciences, which acquired it in 2024 from River Capital.

Hand-verified · updated 2026-06-30

Open JSON · CC-BY
River Capital
Investor
River Capital
NW Fund for Biomedical · 2010 · Healthcare

Key facts

HQUK
SectorHealthcare
StatusAcquired
Key takeaways
  • ·Fully exited in 2024 to Synexa Life Sciences.
  • ·Best return: 4.0x MOIC by River Capital (2024 exit).
Exit Type
Trade Sale
Buyer
Synexa Life Sciences
MOIC
4.0x
Exit Year
2024

More from NW Fund for Biomedical

Other portfolio companies in the same fund.

Questions

Who owns Alderley Analytical?

Alderley Analytical is now owned by Synexa Life Sciences, which acquired it in 2024 from River Capital.

When did Synexa Life Sciences acquire Alderley Analytical?

Synexa Life Sciences acquired Alderley Analytical in 2024, buying from River Capital.

Who did Alderley Analytical sell to?

River Capital sold Alderley Analytical to Synexa Life Sciences in 2024 (Trade Sale), 4.0x return.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue